Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Fluticasone Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Fluticasone propionate Manufacturers in India Suppliers Fluticasone propionate Exporters Distributors Fluticasone propionate api active pharmaceuticals ingredients Fluticasone propionate manufacturers Side Effects bulk drugs raw material Fluticasone propionate companies Side Effects Importers Fluticasone propionate Fluticasone propionate Exporters Fluticasone propionate exporters FDA Fluticasone propionate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Fluticasone propionate manufacturing pharmaceutical drugs pharmaceutical intermediates Fluticasone propionate pharmaceutical chemicals pharmaceutical raw materials Fluticasone propionate active pharmaceutical ingredients Fluticasone propionate committee active pharmaceutical ingredients manufacturer Fluticasone propionate Active Pharmaceutical Ingredients manufacturer Fluticasone propionate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Fluticasone propionate, Fluticasone propionate manufacturer India, Fluticasone propionate product, Fluticasone propionate products, Api preparation, Certificate of Analysis API manufacturer product, Fluticasone propionate anti ulcer product, Certificate of Origin COA Fluticasone propionate COS Fluticasone propionate, pharmaceutical generic, pharmaceutical drug, medical, Fluticasone propionate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Fluticasone propionate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Fluticasone propionate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Fluticasone propionate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Fluticasone propionate ingredients, api, HIV Fluticasone propionate, tablets, capsules, syrup & protein Fluticasone propionate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Fluticasone propionate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Fluticasone propionate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Fluticasone












 










 

 

HOME >> API >> API List1 >> Fluticasone propionate >> Pharmalogy

Fluticasone Propionate Molecular Weight 500.57

PHARMALOGY
Fluticasone propionate CAS Registry Number 80474-14-2

Mechanism of Action: Fluticasone propionate is a synthetic, trifluorinated corticosteroid with anti-inflammatory activity. In vitro dose response studies on a cloned human glucocorticoid receptor system involving binding and gene expression afforded 50% responses at 1.25 and 0.17 nM concentrations, respectively. Fluticasone propionate was 3-fold to 5-fold more potent than dexamethasone in these assays. Data from the McKenzie vasoconstrictor assay in man also support its potent glucocorticoid activity.

In preclinical studies, fluticasone propionate revealed progesterone-like activity similar to the natural hormone. However, the clinical significance of these findings in relation to the low plasma levels
is not known.Distribution: Following intravenous administration, the initial disposition phase for fluticasone propionate was rapid and consistent with its high lipid solubility and tissue binding. The volume of distribution averaged 4.2 L/kg.Metabolism: The total blood clearance of fluticasone propionate is high (average, 1,093 mL/min), with renal clearance accounting for less than 0.02% of the total. The only circulating metabolite detected in man is the 17β-carboxylic acid derivative of fluticasone propionate, which is formed through the cytochrome P450 3A4 pathway. This inactive metabolite had less affinity (approximately 1/2,000) than the parent drug for the glucocorticoid receptor of human lung cytosol in vitro and negligible pharmacological activity in animal studies.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
PHARMALOGY >>
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Fluticasone Propionate

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.